CJC-1295 (No DAC) and Ipamorelin are synthetic peptides commonly investigated together for their complementary roles in growth hormone signaling. Researchers have shown significant interest in this combination because CJC-1295 (No DAC) acts as a growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin selectively activates the ghrelin (GHSR-1a) receptor to stimulate growth hormone release. By studying these pathways, scientists aim to better understand mechanisms involved in endocrine signaling, tissue biology, recovery processes, and metabolic regulation.

Laboratory, animal, and limited human studies have investigated this peptide combination in endocrine and metabolic research. Ongoing research continues to explore the biological interactions between GHRH and ghrelin receptor signaling, as well as their effects on growth hormone physiology.

Current Areas of Investigation

• Growth hormone signaling
• Growth hormone secretagogue research
• Tissue repair and regeneration
• Body composition
• Metabolic regulation

Research Focus

Technical Specifications

Appearance
Lyophilized white powder

Storage Requirements
Store desiccated at −20°C for long-term molecular stability.

Research Disclaimer

CJC-1295 (No DAC) & Ipamorelin supplied by Nomad Clinical is intended exclusively for laboratory research purposes. It is not approved as a medicinal product or food supplement and is not intended for human or veterinary use. References to published scientific literature are provided for educational purposes to summarize current areas of research and should not be interpreted as claims regarding the safety, efficacy, or intended use of this product.